Cargando…
Neuroprotectants in the Era of Reperfusion Therapy
For decades, numerous pharmacological and non-pharmacological strategies have been evaluated without success to limit the consequences of the ischemic cascade, but more rarely the therapies were explored as add on remedies on individuals also receiving reperfusion therapies. It is plausible that the...
Autor principal: | Chamorro, Ángel |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Korean Stroke Society
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6007301/ https://www.ncbi.nlm.nih.gov/pubmed/29886725 http://dx.doi.org/10.5853/jos.2017.02901 |
Ejemplares similares
-
Refocusing Neuroprotection in Cerebral Reperfusion Era: New Challenges and Strategies
por: Xiong, Xiao-Yi, et al.
Publicado: (2018) -
Reperfusion therapy in acute ischemic stroke: dawn of a new era?
por: Bhaskar, Sonu, et al.
Publicado: (2018) -
Nucleobase-Derived Nitrones: Synthesis and Antioxidant and Neuroprotective Activities in an In Vitro Model of Ischemia–Reperfusion
por: Chamorro, Beatriz, et al.
Publicado: (2022) -
The Future of Ischemic Stroke: Flow from Prehospital Neuroprotection to Definitive Reperfusion
por: Ip, Hing Lung, et al.
Publicado: (2014) -
A retrospect and outlook on the neuroprotective effects of anesthetics in the era of endovascular therapy
por: Zhang, Tianhao, et al.
Publicado: (2023)